Evidence map›Paper›PMID 33824590›Full record

ArticleInternational journal of nanomedicine2021

Evaluation of Antitumor Efficacy of Chitosan-Tamarind Gum Polysaccharide Polyelectrolyte Complex Stabilized Nanoparticles of Simvastatin.

Rishabha Malviya, Shakshi Raj, Shivkanya Fuloria, Vetriselvan Subramaniyan, Kathiresan Sathasivam, Usha Kumari, Dhanalekshmi Unnikrishnan Meenakshi, Omji Porwal, Darnal Hari Kumar, Amit Singh and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 56 citations in OpenAlex.

  1. The Health Benefits ofNutrients · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Heliyon · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. pH ResponsiveInternational journal of molecular sciences · 2022
    Article
  13. Synthesis of Novel Tamarind Gum-Gels (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Rishabha Malviya *Department of Pharmacy, SMAS, Galgotias University, Greater Noida, U.P., India.
Shakshi Raj *Department of Pharmacy, SMAS, Galgotias University, Greater Noida, U.P., India.
Shivkanya Fuloria *Department of Pharmaceutical Chemistry, Faculty of Pharmacy, AIMST University, Kedah, 08100, Malaysia.
Vetriselvan Subramaniyan *Department of Pharmacology, Faculty of Medicine, Bioscience and Nursing, MAHSA University, Kuala Lumpur, 42610, Malaysia.
Kathiresan SathasivamDepartment of Biotechnology, Faculty of Applied Science, AIMST University, Kedah, 08100, Malaysia.
Usha KumariDepartment of Physiology, Faculty of Medicine, AIMST University, Kedah, 08100, Malaysia.
Dhanalekshmi Unnikrishnan MeenakshiDepartment of Pharmacology, College of Pharmacy, National University of Science and Technology, Muscat, 130, Oman.
Omji PorwalDepartment of Pharmacognosy, Faculty of Pharmacy, Tishk International University, Erbil, 44001, KRG, Iraq.
Darnal Hari KumarDepartment of Pathology, Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Johor Bahru, 80200, Malaysia.
Amit SinghDepartment of Pharmacy, SMAS, Galgotias University, Greater Noida, U.P., India.
Srikumar ChakravarthiDepartment of Pathology, Faculty of Medicine, Bioscience and Nursing, MAHSA University, Kuala Lumpur, 42610, Malaysia.ORCID 0000-0002-9888-3301
Neeraj Kumar Fuloria *Department of Pharmaceutical Chemistry, Faculty of Pharmacy, AIMST University, Kedah, 08100, Malaysia.
AIMST University · MYGalgotias University · INMahsa University · MYMonash University Malaysia · MYMuscat College · OMTishk International University · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe present study was intended to fabricate chitosan (Ch)-tamarind gum polysaccharide (TGP) polyelectrolyte complex stabilized cubic nanoparticles of simvastatin and evaluate their potential against human breast cancer cell lines. MATERIALS AND

methodsThe antisolvent precipitation method was used for formulation of nanoparticles. Factorial design (3

resultsFormulated nanoparticles showed high entrapment efficiency (67.19±0.42-83.36±0.23%) and small size (53.3-383.1 nm). The present investigation involved utilization of two biological membranes (egg and tomato) as biological barriers for drug release. The study revealed that drug release from tomato membranes was retarded (as compared to egg membranes) but the release pattern matched that of egg membranes. All formulations followed the Baker-Lansdale model of drug release irrespective of the two different biological barriers. Stability studies were carried out for 45 days and exhibited less variation in particle size as well as a reduction in entrapment efficiency. Simvastatin loaded PEC stabilized nanoparticles exhibited better control on growth of human breast cancer cell lines than simple simvastatin. An unusual anticancer effect of simvastatin nanoparticles is also supported by several other research studies.

conclusionThe present study involves first-time synthesis of Ch-TGP polyelectrolyte complex stabilized nanoparticles of simvastatin against MCF-7 cells. It recommends that, in future, theoretical modeling and IVIVC should be carried out for perfect designing of delivery systems.

Indexed as

Antineoplastic AgentsCell DeathChitosanDrug CarriersDrug Delivery SystemsDrug LiberationHumansMCF-7 CellsNanoparticlesParticle SizePlant GumsPolyelectrolytesPolysaccharidesSimvastatinSpectrophotometry, InfraredStatic ElectricityAntineoplastic AgentsChitosanDrug CarriersPlant GumsPolyelectrolytesPolysaccharidesSimvastatinbreast cancercubic nanoparticlespolyelectrolytepolysaccharidesimvastatintamarind

Identifiers

PMID33824590
PMCPMC8018389
OpenAlexW3148879348

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.